| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |